Clinical Trial Update: Treatment With Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) With Acute Myeloid Leukemia: A Single Institution Experience.

View source ↗

Summary

This clinical trial update summarizes results from a single-institution experience using low-dose cytarabine in elderly patients (70 years or older) with acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Acute Myeloid Leukemia | Status: COMPLETED